Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Exposure of rats to exogenous endocrine disruptors 17alpha-ethinylestradiol and benzo(a)pyrene and an estrogenic hormone estradiol induces expression of cytochromes P450 involved in their metabolism

L. Borek-Dohalska, Z. Klusonova, J. Holecova, M. Martinkova, F. Barta, H. Dracinska, T. Cajthaml, M. Stiborova,

. 2016 ; 37 (Suppl1) : 84-94.

Language English Country Sweden

Document type Journal Article

OBJECTIVES: The term "endocrine disruptor" (ED) is used for compounds that mimic or antagonize the effects of endogenous hormones. Synthetic estrogen 17α-ethinylestradiol (EE2) and a human carcinogen benzo[a]pyrene (BaP) are assigned as exogenous endocrine disruptors and an estrogenic hormone estradiol is a natural endogenous disruptor. Here, the potency of these three disruptors administered to rats individually and in combination to induce expression of cytochrome P450 (CYP) enzymes involved in their own metabolism (CYP1A1, 2C and 3A) in vivo was investigated. METHODS: Changes in CYP protein expression after exposure of rats to BaP, EE2 or estradiol were analyzed by Western blotting. Using the HPLC method, CYP1A1, 2C and 3A specific activities in hepatic microsomes isolated from exposed rats were analyzed. RESULTS: Whereas exposure to BaP induces expression of CYP1A1 protein and its marker activity (Sudan I oxidation) in liver, kidney and lung of rats, no significant induction of this CYP and its enzyme activity was produced by EE2 and estradiol. Treatment of BaP in combination with EE2 and/or estradiol decreased the BaP-mediated CYP1A1 induction in liver of exposed rats. BaP also induces CYP2C11 protein in rat liver and kidney, but does not increase its enzyme activity measured as testosterone 16α-hydroxylation. The enzyme activity of another enzyme of the 2C subfamily, CYP2C6, diclofenac 4'-hydroxylation, is even decreased by BaP. The CYP2C11 protein expression and/or its activity are also increased in liver of rats treated with EE2 and estradiol, but its expression is significantly decreased in lung. The CYP2C6 activity is also elevated by treatment of rats with EE2 and estradiol administered individually as well as in their combination. Whereas only a slight increase in CYP3A protein expression was found by BaP in rat liver, its enzyme activity, testosterone 6β-hydroxyalation, increased significantly in this organ. In contrast, no effect or even a decrease in CYP3A expression and its enzyme activity was produced by EE2 and estradiol in rats exposed to these compounds.

000      
00000naa a2200000 a 4500
001      
bmc17023228
003      
CZ-PrNML
005      
20250423153145.0
007      
ta
008      
170720s2016 sw f 000 0|eng||
009      
AR
035    __
$a (PubMed)28263535
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sw
100    1_
$a Borek-Dohalska, Lucie $u Department of Biochemistry, Faculty of Science, Charles University, Prague 2, Czech Republic.
245    10
$a Exposure of rats to exogenous endocrine disruptors 17alpha-ethinylestradiol and benzo(a)pyrene and an estrogenic hormone estradiol induces expression of cytochromes P450 involved in their metabolism / $c L. Borek-Dohalska, Z. Klusonova, J. Holecova, M. Martinkova, F. Barta, H. Dracinska, T. Cajthaml, M. Stiborova,
520    9_
$a OBJECTIVES: The term "endocrine disruptor" (ED) is used for compounds that mimic or antagonize the effects of endogenous hormones. Synthetic estrogen 17α-ethinylestradiol (EE2) and a human carcinogen benzo[a]pyrene (BaP) are assigned as exogenous endocrine disruptors and an estrogenic hormone estradiol is a natural endogenous disruptor. Here, the potency of these three disruptors administered to rats individually and in combination to induce expression of cytochrome P450 (CYP) enzymes involved in their own metabolism (CYP1A1, 2C and 3A) in vivo was investigated. METHODS: Changes in CYP protein expression after exposure of rats to BaP, EE2 or estradiol were analyzed by Western blotting. Using the HPLC method, CYP1A1, 2C and 3A specific activities in hepatic microsomes isolated from exposed rats were analyzed. RESULTS: Whereas exposure to BaP induces expression of CYP1A1 protein and its marker activity (Sudan I oxidation) in liver, kidney and lung of rats, no significant induction of this CYP and its enzyme activity was produced by EE2 and estradiol. Treatment of BaP in combination with EE2 and/or estradiol decreased the BaP-mediated CYP1A1 induction in liver of exposed rats. BaP also induces CYP2C11 protein in rat liver and kidney, but does not increase its enzyme activity measured as testosterone 16α-hydroxylation. The enzyme activity of another enzyme of the 2C subfamily, CYP2C6, diclofenac 4'-hydroxylation, is even decreased by BaP. The CYP2C11 protein expression and/or its activity are also increased in liver of rats treated with EE2 and estradiol, but its expression is significantly decreased in lung. The CYP2C6 activity is also elevated by treatment of rats with EE2 and estradiol administered individually as well as in their combination. Whereas only a slight increase in CYP3A protein expression was found by BaP in rat liver, its enzyme activity, testosterone 6β-hydroxyalation, increased significantly in this organ. In contrast, no effect or even a decrease in CYP3A expression and its enzyme activity was produced by EE2 and estradiol in rats exposed to these compounds.
650    _2
$a zvířata $7 D000818
650    _2
$a benzopyren $x farmakologie $7 D001564
650    _2
$a systém (enzymů) cytochromů P-450 $x metabolismus $7 D003577
650    _2
$a endokrinní disruptory $x farmakologie $7 D052244
650    _2
$a estradiol $x farmakologie $7 D004958
650    _2
$a estrogeny $x farmakologie $7 D004967
650    _2
$a ethinylestradiol $x farmakologie $7 D004997
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a jaterní mikrozomy $x metabolismus $7 D008862
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
655    _2
$a časopisecké články $7 D016428
700    1_
$a Klusonova, Zuzana $u Department of Biochemistry, Faculty of Science, Charles University, Prague 2, Czech Republic.
700    1_
$a Holecova, Jana $u Department of Biochemistry, Faculty of Science, Charles University, Prague 2, Czech Republic.
700    1_
$a Martinkova, Marketa $u Department of Biochemistry, Faculty of Science, Charles University, Prague 2, Czech Republic.
700    1_
$a Bárta, František $u Department of Biochemistry, Faculty of Science, Charles University, Prague 2, Czech Republic. $7 xx0331419
700    1_
$a Dracinska, Helena $u Department of Biochemistry, Faculty of Science, Charles University, Prague 2, Czech Republic.
700    1_
$a Cajthaml, Tomas $u Institute of Microbiology, Academy of Science of the Czech Republic, Prague 4, Czech Republic.
700    1_
$a Stiborova, Marie $u Department of Biochemistry, Faculty of Science, Charles University, Prague 2, Czech Republic.
773    0_
$w MED00168352 $t Neuro-endocrinology letters $x 0172-780X $g Roč. 37, Suppl1 (2016), s. 84-94
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28263535 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170720 $b ABA008
991    __
$a 20250423153145 $b ABA008
999    __
$a ok $b bmc $g 1238909 $s 984141
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 37 $c Suppl1 $d 84-94 $i 0172-780X $m Neuro-endocrinology letters $n Neuro-endocrinol. lett. $x MED00168352
LZP    __
$a Pubmed-20170720

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...